JSA, TT&A, Baker & McKenzie advise brokers on Mylan Inc's ₹3,679 crore exit from Biocon
Mylan Inc. has divested its entire stake of upto 5.64% in Biocon Limited on the screen-based trading platform of the BSE Limited and the National Stock Exchange of India for ₹3,679 crore, making a complete exit. JSA Advocates & Solicitors has advised Jefferies India, one of the brokers on this stake sale. The transaction was led by Arka Mookerjee (Partner), with support from Pracheta Bhattacharya (Partner) and Arjun Rastogi (Principal Associate).
Sources
- Bar & Bench - Dealstreet
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Morrison Foerster, Khaitan & Co advises Autodesk on acquisition of select tech assets, intellectual property from BIMDeX28 Oct 2026
- Shardul Amarchand Mangaldas, ALMT Legal, JSA act on Tonbo Imaging ₹852 crore IPO27 Oct 2026 · ₹852 cr
- Trilegal acts on Fusion CX ₹702 crore IPO26 Oct 2026 · ₹702 cr
- Fox & Mandal, Shardul Amarchand Mangaldas act on Canada-based Infotech acquiring Zluri26 Oct 2026
- TT&A, A&O Shearman advise broker on sale of ₹250 crore Anthem Biosciences shares by Portsmouth Tech26 Oct 2026 · ₹250 cr
- HCL Technologies Limited: General Updates26 Oct 2026